28 Jun 2021 | 02:23 pm |
Multinational law firm Pinsent Masons has advised Bryan, Garnier & Co on the successful EUR 20m capital increase of Heidelberg Pharma AG.
The transaction increased German based biopharmaceutical company Heidelberg Pharma AG’s share capital by approximately 10%, with the 3,106,637 newly issued shares offered to qualified institutional investors in Europe and the United States in an accelerated book-building process. At a subscription price of EUR 6.44 per share, the company raised gross proceeds of EUR 20 million.
The new shares were admitted to trading on the Frankfurt Stock Exchange on June 21, 2021.
Pinsent Masons advised Bryan, Garnier & Co, the sole global coordinator and sole bookrunner for the transaction. Bryan, Garnier & Co is one of the most active investment banks in the European growth sector, with a particular focus on healthcare, technology, consumer goods and business services. They are a fully registered broker-dealer, licensed and supervised by the FCA in Europe and FINRA in the US.
The Pinsent Masons team was led by Dr Susanne Lenz, LL.M. and included Roberta Markovina (Partner, London), Dušan Stojković (Senior Associate, Frankfurt) and Sara Šepac (Associate, Frankfurt).
Commenting on the transaction, Dr Susanne Lenz said:
"We are pleased to have worked with Bryan Garnier on this exciting and important transaction. With Heidelberg Pharma AG’s expertise in oncology, we are proud to have been part of the successful financing of a company on the cutting edge of biopharmaceutical research and development in Germany."
Multinational law firm Pinsent Masons, in collaboration with the world-renowned art and design college Central Saint Martins (CSM), University of the Arts London has announced the winner of its inaugural Prize celebrating emerging creative talent at an exhibition at its London headquarters, Crown Place.
Multinational law firm Pinsent Masons has advised two subsidiaries of Arch Re – Southern Rock Insurance Company Limited (Southern Rock) and Alwyn Insurance Company Limited (Alwyn) – on the successful completion of an insurance business transfer under Part VII of the Financial Services and Markets Act 2000.
Multinational law firm Pinsent Masons has advised Southeast Asia-based clean energy developer Alba Renewables on its acquisition by a leading global investment firm.
Multinational law firm Pinsent Masons has advised on the recommended public takeover of AIM-listed Idox plc (Idox) by Frankel Bidco Limited, a vehicle that is indirectly owned by funds managed by Long Path Partners.
Multinational law firm Pinsent Masons has advised International Finance Corporation (IFC), the largest global development institution focused on the private sector in emerging markets, on its first ever investment in Bhutan’s energy and infrastructure sectors.
Multinational law firm Pinsent Masons has today unveiled its unaudited financial results for the year ending 30 April 2025. This year's results have delivered a revenue increase of 4.7% after a year of continued growth within the firm’s core sectors and across its jurisdictions.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]
